Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1998
06/09/1998US5763398 Sprayable aqueous solution for drug delivery yields uniform plasma levels of the desmopressin peptide
06/09/1998US5763397 Glycopeptides, a process for their preparation and their use
06/09/1998US5763396 Method of treating or preventing type 1 diabetes by oral administration of insulin
06/09/1998US5763395 Stable bactericidal mixtures for use in mouth washes or cosmetics
06/09/1998US5763394 Human growth hormone aqueous formulation
06/09/1998US5763393 Ability to bind n-methylasperate receptors; treatment fornervous system disorders
06/09/1998US5763392 Nutritional supplyment for reducing blood glucose concentration
06/09/1998US5763284 Methods for peptide synthesis and purification
06/09/1998US5763276 Processes for the purification of human recombinant decorin and the detection of guandinium ions
06/09/1998US5763274 Antibody 103B2
06/09/1998US5763271 Vasodilatory and immune suppressant peptides
06/09/1998US5763268 Hepatitis delta virus compositions and expression vectors
06/09/1998US5763253 Methods of preparing tissue plasiminogen activator derivative composition
06/09/1998US5763251 Viral products
06/09/1998US5763250 Chimeric toxins
06/09/1998US5763248 CDNA encoding a human ATP synthase Fo subunit (ASYSD)
06/09/1998US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763224 Genetic engineered complementary dna
06/09/1998US5763223 DNA encoding a cytokine that induces apoptosis
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763218 Nucleic acid encoding novel human G-protein coupled receptor
06/09/1998US5763217 Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763213 Sensory and motor neuron derived factor (SMDF)
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763210 Recombinant production of interferon-gamma binding proteins
06/09/1998US5763209 Methods and materials relating to the functional domains of DNA binding proteins
06/09/1998US5763205 Producing pure chondroitinase ABC from Proteus vulgaris ATCC 6896
06/09/1998US5763202 Medical diagnosis of prostate cancer; enzyme-linked immunosorbent assay
06/09/1998US5763200 Inhibition of amylin release
06/09/1998US5763197 Human hematopoietic stem cell
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5763190 Detecting the human immunodeficiency virus type i protein
06/09/1998US5763174 RNA editing enzyme and methods of use thereof
06/09/1998US5763173 Nucleic acid ligand inhibitors to DNA polymerases
06/09/1998US5763164 Immunogenic cancer proteins and peptides and methods of use
06/09/1998US5763160 Detecting antibodies to hiv and neutralizing antibodies to hiv-gp120 in an immunoassay by using polypeptide or conjugate of polypeptide, polylysine of peptide 127 or mixtures
06/09/1998US5763156 Effective in regulating inflammatory platelet and endothelial sitmulatory and coagulopathic responses by modulating the activity of the c5b-9 complex of the human plasma complement system by adding a fluorescent potentiometric dye
06/09/1998US5762965 Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres
06/09/1998US5762948 Moist bacteriocin disinfectant wipes and methods of using the same
06/09/1998US5762943 And deacylated monophosphoryl lipid, carrier, and allergen
06/09/1998US5762937 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
06/09/1998US5762934 Clostridium difficile toxin disease therapy
06/09/1998US5762933 Administering
06/09/1998US5762931 Anti-cancer utility of HCG vaccines
06/09/1998US5762930 Bispecific reagents for redirected targeting of human lipoproteins
06/09/1998US5762929 Anti-motoneuron-disease agent
06/09/1998US5762926 Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
06/09/1998US5762923 Stabilized interferon alpha solutions
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998US5762921 Composition and methods for the treatment of tumors
06/09/1998US5762920 Megakaryocyte production
06/09/1998US5762916 Cosmetic and/or pharmaceutical preparations
06/09/1998US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus
06/04/1998WO1998023959A2 Diagnosis and treatment of insulin-dependent diabetes mellitus
06/04/1998WO1998023782A2 A new ets-related gene overexpressed in human breast and epithelial cancers
06/04/1998WO1998023781A1 Ligand detection system and methods of use thereof
06/04/1998WO1998023780A1 Methods for diagnosing and treating diabetes
06/04/1998WO1998023775A2 Dna for evaluating the progression potential of cervical lesions
06/04/1998WO1998023765A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
06/04/1998WO1998023761A1 HUMANIZED ANTI-CD11a ANTIBODIES
06/04/1998WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998WO1998023758A1 Human glutathione s-transferase
06/04/1998WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/04/1998WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
06/04/1998WO1998023751A1 Processed polypeptides with il-16 activity, processes for their production and their use
06/04/1998WO1998023750A2 Mammalian chemokines
06/04/1998WO1998023749A1 Fibroblast growth factor-13
06/04/1998WO1998023748A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
06/04/1998WO1998023746A1 Antibody mutants
06/04/1998WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998WO1998023744A1 Novel human rna-binding protein
06/04/1998WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998WO1998023742A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
06/04/1998WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
06/04/1998WO1998023740A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998WO1998023739A1 Novel gene encoding male-transplantation antigen
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023735A1 Immune responses using compositions containing stress proteins
06/04/1998WO1998023730A1 Compounds and methods for treating cancer
06/04/1998WO1998023728A1 Cellular adjuvant
06/04/1998WO1998023644A1 Peptide derivatives
06/04/1998WO1998023643A1 Multimeric erythropoietin with increased biological activity
06/04/1998WO1998023639A2 ShK TOXIN COMPOSITIONS AND METHODS OF USE
06/04/1998WO1998023638A2 Complement inhibitor
06/04/1998WO1998023637A1 Cyclohexapeptides having antimicrobial activity
06/04/1998WO1998023636A1 Heptapeptide oxytocin analogues
06/04/1998WO1998023631A1 Novel bacterial polypeptides and polynucleotides
06/04/1998WO1998023625A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998WO1998023588A1 Metalloproteinase inhibitors
06/04/1998WO1998023294A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998WO1998023289A1 MODULATION OF IgG BINDING TO FcRn
06/04/1998WO1998023286A2 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy
06/04/1998WO1998023285A1 Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis b
06/04/1998WO1998023284A1 Method of regulating nitric oxide production
06/04/1998WO1998023283A1 Methods of inhibiting protein degradation to combat muscle wasting
06/04/1998WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998WO1998023281A1 ANTIFUNGAL COMPOUNDS FROM $i(PSEUDOMONAS VIRIDIFLAVA)
06/04/1998WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
1 ... 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 ... 3163